Literature DB >> 2401358

Abnormal behavior of protein kinase C in the human myeloma cell line, RPMI 8226.

M R Parant1, B Klein, H Vial.   

Abstract

Protein kinase C activity of the human myeloma cell line, RPMI 8226, was studied after prepurification on DEAE-cellulose. The total protein kinase activity, eluted at 0.12 M NaCl, was 493 nmol/min/10(10) cells, but 38% was associated with membranes. The lipid dependence of cytosolic and membrane activities was only 52% and 21%, respectively. This activity increased with time, to as much as 200% for the membrane fraction after 7 days, whereas lipid dependence and the PDBu binding properties were lost. This modified activity was not due to the extinction of a copurifying endogenous inhibitor nor to classical PKC proteolysis. TPA-treatment of these cels is accompanied by a rapid, selective and complete loss of lipid-dependent activity of the cytosol, thus benefiting co-migrating lipid independent activity, with no membrane fraction recovery or PKM formation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2401358     DOI: 10.1016/0014-5793(90)81187-s

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  2 in total

1.  Targeting PKC in multiple myeloma: in vitro and in vivo effects of the novel, orally available small-molecule inhibitor enzastaurin (LY317615.HCl).

Authors:  Klaus Podar; Marc S Raab; Jing Zhang; Douglas McMillin; Iris Breitkreutz; Yu-Tzu Tai; Boris K Lin; Nikhil Munshi; Teru Hideshima; Dharminder Chauhan; Kenneth C Anderson
Journal:  Blood       Date:  2006-10-05       Impact factor: 22.113

2.  14-3-3ζ interacts with stat3 and regulates its constitutive activation in multiple myeloma cells.

Authors:  Jia Zhang; Fangjin Chen; Wenliang Li; Qian Xiong; Mingkun Yang; Peng Zheng; Chongyang Li; Jianfeng Pei; Feng Ge
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.